Introduction
Adenosine is a ubiquitous physiological regulator and neuromodulator capable of ultiple physiological actions in various systems [1] . Adenosine receptors are members of the G-protein-coupled receptor superfamily, and comprise A 1 , A 2a , A 2b , and A 3 adenosine receptors, identified by convergent data from molecular, biochemical, and pharmacological studies [2] . A 1 R is widely expressed in the brain, adipose tissue, the testis, and the spinal cord [3] . Via A 1 R, adenosine reduces heart rate [4] , glomerular filtration rate, and renin release in the kidney [5] , induces bronchoconstriction [6, 7] and inhibits
Abstract
Aim: To study the modulating effect of adenosine deaminase (ADA) on yhe adenosine A 1 receptor (A 1 R) in HEK293 cells stably expressing the human A 1 R. Methods: cDNA was amplified by RT-PCR using total RNA from human embryo brain tissue as the template. The PCR products were subcloned into the plasmid pcDNA3 and cloned into the plasmid pcDNA3.1. The cloned A 1 R cDNA was sequenced and stably expressed in HEK293 cells. The modulating effect of adenosine deaminase on A 1 R was studied by using [ [8] [9] [10] , which mediate the inhibition of adenylyl cyclase [11 ] and regulate Ca 2+ and K + channels and inositol phosphate metabolism [12] . A 1 R present two different affinities for agonists, which have classically been attributed to a different coupling to heterotrimeric G proteins [13] , coupled receptor-G protein complexes display high affinity for A 1 R agonists, whereas uncoupled receptors display low affinity [13, 14] . Adenosine deaminase (ADA, E.C.3.5.4.4) is an enzyme which catalyzes the hydrolytic deamination of adenosine to inosine. ADA is located both in the cytosol and on the cell membrane. Recent evidence suggest that ecto-ADA had extra-enzymatic and co-stimulatory functional roles. ADA modulates ligand binding and signaling through A 1 R on DDT 1 MF-2 cells, a smooth muscle cell line [15] . ADA seems to be necessary for the high affinity binding of agonists to A 1 R [16, 17] . In the present study, the effect of ADA on the ligand-mediated regulation of A 1 R in HEK293 cells stably expressing human A 1 R has been studied.
Materials and methods
Materials High glucose Dulbecco's modified Eagle's medium (DMEM), fetal calf serum, G418, benzylpenicillin and streptomycin were obtained from Gibco. Restricted enzyme (HindIII, EcoRI, XhoI), T4 DNA ligase, reverse transcriptase enzyme and buffer were purchased from Promega (USA). Pyrobest DNA polymerase and PCR buffer were obtained from TaKaRa (Dalian, China). -cyclopentyladenosine (CCPA) were obtained from RBI (Natick, MA, USA). Adenosine deaminase was obtained from Roche Biochemicals (Mannheim, Germany). Fluo-3/AM, p-(dipropylsulfamoyl)benzoic acid, pluronic F-127, HEPES, Triton X-100, bovine serum albumin, leupeptin, pepstatin A, aprotinin and PMSF were purchased from Sigma (USA). Cloning of the human A 1 R cDNA Human brain total RNA was obtained from human embryo brain tissue. The total RNA was reverse-transcribed using oligo-dT18 as a primer. With the cDNA, PCR was carried out using the primers A 1 R-1SE and A 1 R-1AS (Table 1) . Gel-purified PCR product was treated with EcoRI/XhoI and subcloned into the EcoRI/XhoI site of the mammalian expression vector pcDNA3. With the subcloned A 1 R-pcDNA3 plasmid as template, PCR was carried out using the primers A 1 R-2SE and A 1 R-2AS (Table 2) , which resulted in full length codon sequence cDNA. Gel-purified PCR product was treated with HindIII/EcoRI and cloned into the HindIII/EcoRI site of the mammalian expression vector pcDNA3.1(+).
Production of HEK293 cell lines stably expressing human A 1 R HEK293 Cells were transfected with the A 1 RpcDNA3.1(+) expression vector, using the Lipofectamine2000 reagent. Cells were treated with selection medium containing G418 (1 g/L) for 3 weeks to select stably transfected cells displaying neomycin resistance. Between 2 and 3 weeks in the selection process, resistant cells began to appear. They were sought out by serial dilutions and allowed to grow from single cells. Receptor expression of single cell-derived colonies was tested by radioligand binding assay. 
Cell culture Human embryonic kidney (HEK293) cells were cultured in DMEM containing streptomycin (100 mg/L), benzylpenicillin (1000 kU/L) and fetal bovine serum (10%). Cells were incubated at 37 °C in 5% CO 2 . Stably transfected HEK293 cell lines were cultured in DMEM high glucose medium containing streptomycin (100 mg/L), benzylpenicillin (1000 kU/L), G-418 (200 mg/L), and fetal bovine serum (10%). Cells were incubated at 37 °C in 5% CO 2 4 ) and centrifuged again under the same conditions. Finally, the pellet was resuspended in the same buffer, and protein concentration was determined by using the BCA Kit (Pierce) as described previously [18] . [17] . After this treatment, cells were incubated for 1 h at 37 °C with [ After incubation for 1 h, the binding assays were stopped by rapid filtration through Whatman GF/B filters, and the filters were immediately washed three times with ice-cold buffer. Filters were then transferred to Eppendoff tubes, and scintillation liquid was added to measure the radioactivity.
Intracellular Ca
2+ measurements Ca 2+ fluorescence measurements were performed using a NOVOstar plate reader with a pipettor system (BMG labtechnologies, Offenburg, Germany). A 1 cells were harvested with 0.05% trypsin/0.02% EDTA and rinsed with high glucose DMEM containing 10% fetal bovine serum, streptomycin 100 mg/L, and benzylpenicillin 1000 kU/L. Pelleted cells were resuspended in fresh medium and kept under 5% CO 2 at 37 °C for 1 h and vortexed every 15 min. After two washes with Krebs-HEPES buffer, cells were loaded with Fluo-3/AM 5 µmol/L for 30 min containing 1% pluronic F-127 and p-(dipropylsulfamoyl)benzoic acid 2.5 mmol/L. Then cells were rinsed 3 times with Krebs-HEPES buffer containing 0.5% bovine serum albumin, the diluted, and evenly plated into 96-well plates at a density of 1×10 4 cells/well. Microplates were kept at 37 °C for 15 min [19, 20] . Buffer alone or different concentrations of CPA were then injected sequentially into separate wells, and fluorescence intensity was measured at 520 nm for 50 s at 0.2 s intervals. The excitation wavelength was 485 nm.
[ Data analysis Experiments were performed in triplicate. All data were expressed as mean±SD and data were analyzed with the GraphPad Prism 4.0 program (GraphPad Software, San Diego, CA, USA). Student's t-test was used for statistical analysis.
Results
Cloning of the human adenosine A 1 R cDNA To obtain the cDNA with the full length codon sequence of human A 1 R, a reverse transcription reaction was carried out using the total RNA extracted from human embryo brain tissue. Using cDNA with full length codon sequence of A 1 R, a PCR product (1332 bp) was obtained using primers described previously. The PCR product subcloned into a pcDNA3 plasmid and cDNA (981 bp) containing the full A 1 R codon sequence was obtained using this subcloned vector as a template. The cDNA was then cloned into the mammalian expression vector pcDNA3.1. Sequence analysis demonstrated that the sequence of the constructed A 1 R-pcDNA3.1 expression vector was identical to that of human A 1 R cDNA in the gene bank.
Selection of cell clones Colonies of the selected stable integrants were initially analyzed for human A 1 R expression by using a receptor binding assay using [ Table 2 ).
Effects of A 1 R agonist CPA on intracellular calcium level in the presence or absence of ADA An increase in intracellular Ca 2+ appears to be a universal second messenger signal for a majority of recombinant GPCRs [20] . A 1 R agonists evoked a concentration-dependent and reproducible Ca 2+ signal at A 1 R [22] . To assess the effect of the presence of ADA on A 1 R signal transduction, we performed an intracellular calcium assay. 
Discussion
Recently, several evidences demonstrated that cell-surface ADA interacted with A 1 receptors in brain cortex and DDT 1 MF-2 cells and that the enzyme was able to modulate ligand binding and signaling through A 1 R [16, [21] [22] [23] . By immunoprecipitation and affinity chromatography, it was found that ADA and A 1 R interacted in pig brain cortical membranes. By means of this interaction ADA led to the appearance of the high-affinity site of the receptor. Thus, it seems that ADA is necessary for coupling A 1 R to heterotrimeric G proteins [16] . In Chinese hamster ovary (CHO) cells, stably transfected with the human adenosine A 1 R, it was found that in the presence of ADA, the [ at the high-affinity state [24] . In the present study, human adenosine A 1 R were cloned and stably expressed in the HEK293 cells and the effects of ecto-ADA on adenosine A 1 R were studied. By using competitive inhibition assay of adenosine A 1 R agonists CCPA or CPA against [ 3 H]DPCPX, we found that A 1 R displayed two different affinities for agonists in the presence of ADA. However, A 1 R only displayed a low affinity for agonists in the absence of ADA, suggesting that most of the binding of [ 3 H]DPCPX was associated with the low-affinity site under these conditions and that the interaction of ADA with A 1 adenosine receptors led to the appearance of the high-affinity site of the receptor.
To further demonstrate possible interaction between A 1 R and ADA, intracellular calcium assay was carried out in the present studies. The results demonstrated that the EC 50 value of CPA for inducing increase of intracellular calcium level was lower in the presence of ADA than that in the absence of ADA, suggesting that the presence of ADA may promote signaling through A 1 receptors in the stably transfected HEK293 cells. Our results further support the notion that ADA may promote the signaling through A 1 receptors.
